19:44 , Feb 1, 2019 |  BC Week In Review  |  Clinical News

NIAID says its Ebola therapy is safe

The National Institute of Allergy and Infectious Diseases Vaccine Research Center said IV infusions of its Ebola therapy mAb114 were well tolerated in the open-label, U.S. Phase I VRC 608 trial in 18 healthy adults....
20:19 , Jan 25, 2019 |  BC Extra  |  Clinical News

NIAID says its Ebola therapy is safe

The National Institute of Allergy and Infectious Diseases Vaccine Research Center said IV infusions of its Ebola therapy mAb114 were well tolerated in the open-label, U.S. Phase I VRC 608 trial in 18 healthy adults....
17:57 , Oct 25, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Coronavirus; influenza virus; HIV/AIDS; Ebola Cell culture and rat studies identified lipopeptide-based inhibitors of MERS-CoV S protein, Ebola virus glycoprotein and HIV env that could help treat Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola...
22:07 , Sep 13, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: August 2018

New Therapeutic Targets and Biomarkers: August 2018 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database in August 2018. Therapeutic targets are defined as any protein, gene or other...
23:50 , Aug 8, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Ebola Patient sample, mouse, guinea pig and ferret studies identified three broadly neutralizing mAbs against Ebola virus glycoprotein that could help treat infections by multiple Ebolavirus species. Screening of mAb clones derived from blood...
16:38 , Jul 20, 2018 |  BC Week In Review  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on July 17 proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. CanSino said in its prospectus...
22:18 , Jul 17, 2018 |  BC Extra  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on Tuesday proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. The news comes as multiple media...
22:02 , Jul 17, 2018 |  BC Extra  |  Financial News

CanSino latest to file for HKEX IPO

Vaccines company CanSino Biologics Inc. (Tianjin, China) on Tuesday proposed to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley and CLSA. The news comes as multiple media...
19:18 , Jun 20, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Ebola Patient sample, mouse, guinea pig and ferret studies identified three broadly neutralizing antibodies (bNAbs) against Ebola virus glycoprotein that could help treat infections by multiple Ebolavirus species and strains. Screening of neutralizing antibodies...
18:09 , May 11, 2018 |  BC Week In Review  |  Company News

Merck, J&J vaccines ready for Ebola outbreak

Merck & Co. Inc. (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ) said they are ready to make their respective Ebola vaccines available to the World Health Organization (WHO), which announced an Ebola virus outbreak in the...